{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,22]],"date-time":"2026-08-22T23:22:27Z","timestamp":1787440947780,"version":"build-2736575974"},"reference-count":73,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T00:00:00Z","timestamp":1780531200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100002873","name":"Chulalongkorn University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002873","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine &amp; Pharmacotherapy"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.biopha.2026.119618","type":"journal-article","created":{"date-parts":[[2026,6,6]],"date-time":"2026-06-06T22:30:14Z","timestamp":1780785014000},"page":"119618","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Sigma-1 Receptor antagonism potentiates siramesine-induced apoptosis and altered autophagic signaling in human leukemia cells"],"prefix":"10.1016","volume":"200","author":[{"given":"Ankita","family":"Sharma","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kanokphorn Saenawat","family":"Ruckvongacheep","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sirikalaya","family":"Brimson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2074-8262","authenticated-orcid":false,"given":"James Michael","family":"Brimson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.biopha.2026.119618_bib1","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/j.emc.2014.04.004","article-title":"Acute leukemia","volume":"32","author":"Rose-Inman","year":"2014","journal-title":"Emerg. Med. Clin. North. Am."},{"issue":"8","key":"10.1016\/j.biopha.2026.119618_bib2","doi-asserted-by":"crossref","DOI":"10.3390\/genes12081118","article-title":"T-cell acute lymphoblastic leukemia: biomarkers and their clinical usefulness","volume":"12","author":"Bardelli","year":"2021","journal-title":"Genes. (Basel)"},{"issue":"2","key":"10.1016\/j.biopha.2026.119618_bib3","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1002\/gcc.22416","article-title":"Pediatric T-cell acute lymphoblastic leukemia","volume":"56","author":"Karrman","year":"2017","journal-title":"Genes. Chromosomes Cancer"},{"issue":"3","key":"10.1016\/j.biopha.2026.119618_bib4","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1182\/blood.2019001557","article-title":"How I treat newly diagnosed T-cell acute lymphoblastic leukemia and T-cell lymphoblastic lymphoma in children","volume":"135","author":"Teachey","year":"2020","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.biopha.2026.119618_bib5","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1093\/biostatistics\/kxx069","article-title":"Estimation of clinical trial success rates and related parameters","volume":"20","author":"Wong","year":"2019","journal-title":"Biostatistics"},{"issue":"7695","key":"10.1016\/j.biopha.2026.119618_bib6","doi-asserted-by":"crossref","first-page":"S26","DOI":"10.1038\/d41586-018-02483-3","article-title":"Bringing down the cost of cancer treatment","volume":"555","author":"Dolgin","year":"2018","journal-title":"Nature"},{"key":"10.1016\/j.biopha.2026.119618_bib7","series-title":"Seminars in Hematology","first-page":"149","article-title":"The challenge to further improvements in survival of patients with T-ALL: Current treatments and new insights from disease pathogenesis","author":"Dwyer","year":"2020"},{"issue":"28","key":"10.1016\/j.biopha.2026.119618_bib8","doi-asserted-by":"crossref","first-page":"3282","DOI":"10.1200\/JCO.20.00256","article-title":"Children\u2019s Oncology Group AALL0434: a phase III randomized clinical trial testing nelarabine in newly diagnosed T-cell acute lymphoblastic leukemia","volume":"38","author":"Dunsmore","year":"2020","journal-title":"J. Clin. Oncol."},{"issue":"3","key":"10.1016\/j.biopha.2026.119618_bib9","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1182\/blood-2006-05-018192","article-title":"Outcome of 609 adults after relapse of acute lymphoblastic leukemia (ALL); an MRC UKALL12\/ECOG 2993 study","volume":"109","author":"Fielding","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.biopha.2026.119618_bib10","article-title":"Metronomic chemotherapy: a systematic review of the literature and clinical experience","author":"Simsek","year":"2019","journal-title":"J. Oncol. 2019"},{"issue":"3","key":"10.1016\/j.biopha.2026.119618_bib11","doi-asserted-by":"crossref","first-page":"e104","DOI":"10.1016\/S1470-2045(13)70008-1","article-title":"Paediatric cancer in low-income and middle-income countries","volume":"14","author":"Magrath","year":"2013","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.biopha.2026.119618_bib12","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2021.174263","article-title":"Identification and characterization of MAM03055A: a novel bivalent sigma-2 receptor\/TMEM97 ligand with cytotoxic activity","volume":"906","author":"Liu","year":"2021","journal-title":"Eur. J. Pharmacol."},{"issue":"5","key":"10.1016\/j.biopha.2026.119618_bib13","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1080\/14728222.2021.1939681","article-title":"The emerging role of the sigma-1 receptor in autophagy: hand-in-hand targets for the treatment of Alzheimer's","volume":"25","author":"Prasanth","year":"2021","journal-title":"Expert. Opin. Ther. Targets"},{"issue":"10","key":"10.1016\/j.biopha.2026.119618_bib14","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1080\/14728222.2020.1805435","article-title":"Using sigma-ligands as part of a multi-receptor approach to target diseases of the brain","volume":"24","author":"Brimson","year":"2020","journal-title":"Expert. Opin. Ther. Targets"},{"issue":"5","key":"10.1016\/j.biopha.2026.119618_bib15","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1007\/s40263-023-01007-6","article-title":"Targeting sigma receptors for the treatment of neurodegenerative and neurodevelopmental disorders","volume":"37","author":"Malar","year":"2023","journal-title":"CNS Drugs"},{"issue":"27","key":"10.1016\/j.biopha.2026.119618_bib16","doi-asserted-by":"crossref","first-page":"7160","DOI":"10.1073\/pnas.1705154114","article-title":"Identification of the gene that codes for the \u03c3<sub>2<\/sub> receptor","volume":"114","author":"Alon","year":"2017","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"2","key":"10.1016\/j.biopha.2026.119618_bib17","first-page":"408","article-title":"Sigma-1 and sigma-2 receptors are expressed in a wide variety of human and rodent tumor cell lines","volume":"55","author":"Vilner","year":"1995","journal-title":"Cancer Res."},{"issue":"3","key":"10.1016\/j.biopha.2026.119618_bib18","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1002\/med.21297","article-title":"Sigma-2 receptor ligands and their perspectives in cancer diagnosis and therapy","volume":"34","author":"Huang","year":"2014","journal-title":"Med. Res. Rev."},{"issue":"2","key":"10.1016\/j.biopha.2026.119618_bib19","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1016\/j.bbrc.2014.12.029","article-title":"Sigma 1 Receptor antagonist potentiates the anti-cancer effect of p53 by regulating ER stress, ROS production, Bax levels, and caspase-3 activation","volume":"456","author":"Happy","year":"2015","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"2","key":"10.1016\/j.biopha.2026.119618_bib20","first-page":"266","article-title":"Siramesine H Lundbeck","volume":"2","author":"Heading","year":"2001","journal-title":"Curr. Opin. Investig. Drugs"},{"key":"10.1016\/j.biopha.2026.119618_bib21","article-title":"Siramesine triggers cell death through destabilisation of mitochondria, but not lysosomes","volume":"4","author":"Cesen","year":"2013","journal-title":"Cell. Death Dis."},{"issue":"19","key":"10.1016\/j.biopha.2026.119618_bib22","doi-asserted-by":"crossref","first-page":"8975","DOI":"10.1158\/0008-5472.CAN-05-0269","article-title":"Effective tumor cell death by \u03c3-2 receptor ligand siramesine involves lysosomal leakage and oxidative stress","volume":"65","author":"Ostenfeld","year":"2005","journal-title":"Cancer Res."},{"issue":"3","key":"10.1016\/j.biopha.2026.119618_bib23","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/j.ccr.2013.08.003","article-title":"Transformation-associated changes in sphingolipid metabolism sensitize cells to lysosomal cell death induced by inhibitors of acid sphingomyelinase","volume":"24","author":"Petersen","year":"2013","journal-title":"Cancer Cell."},{"key":"10.1016\/j.biopha.2026.119618_bib24","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2016.208","article-title":"Ferroptosis is induced following siramesine and lapatinib treatment of breast cancer cells","volume":"7","author":"Ma","year":"2016","journal-title":"Cell. Death Dis."},{"issue":"8","key":"10.1016\/j.biopha.2026.119618_bib25","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0182921","article-title":"Ferroptosis and autophagy induced cell death occur independently after siramesine and lapatinib treatment in breast cancer cells","volume":"12","author":"Ma","year":"2017","journal-title":"PLoS. One"},{"issue":"4","key":"10.1016\/j.biopha.2026.119618_bib26","doi-asserted-by":"crossref","first-page":"487","DOI":"10.4161\/auto.5774","article-title":"Anti-cancer agent siramesine is a lysosomotropic detergent that induces cytoprotective autophagosome accumulation","volume":"4","author":"Ostenfeld","year":"2008","journal-title":"Autophagy"},{"issue":"16","key":"10.1016\/j.biopha.2026.119618_bib27","doi-asserted-by":"crossref","first-page":"6623","DOI":"10.1158\/0008-5472.CAN-08-0463","article-title":"Sensitization to the lysosomal cell death pathway by oncogene-induced down-regulation of lysosome-associated membrane proteins 1 and 2","volume":"68","author":"Fehrenbacher","year":"2008","journal-title":"Cancer Res."},{"issue":"4","key":"10.1016\/j.biopha.2026.119618_bib28","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1038\/bjc.2011.602","article-title":"Sigma-2 ligands induce tumour cell death by multiple signalling pathways","volume":"106","author":"Zeng","year":"2012","journal-title":"Br. J. Cancer"},{"issue":"1","key":"10.1016\/j.biopha.2026.119618_bib29","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1186\/s12885-017-3162-3","article-title":"Effects of the lysosomal destabilizing drug siramesine on glioblastoma in vitro and in vivo","volume":"17","author":"Jensen","year":"2017","journal-title":"BMC Cancer"},{"issue":"12","key":"10.1016\/j.biopha.2026.119618_bib30","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1038\/s41419-018-1227-0","article-title":"Lysosomotropic drugs activate TFEB via lysosomal membrane fluidization and consequent inhibition of mTORC1 activity","volume":"9","author":"Zhitomirsky","year":"2018","journal-title":"Cell. Death Dis."},{"issue":"6","key":"10.1016\/j.biopha.2026.119618_bib31","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1038\/leu.2016.4","article-title":"Lysosomotropic agents selectively target chronic lymphocytic leukemia cells due to altered sphingolipid metabolism","volume":"30","author":"Dielschneider","year":"2016","journal-title":"Leukemia"},{"issue":"3","key":"10.1016\/j.biopha.2026.119618_bib32","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a035246","article-title":"The Genetics and Mechanisms of T-Cell Acute Lymphoblastic Leukemia","volume":"10","author":"Gianni","year":"2020","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"10.1016\/j.biopha.2026.119618_bib33","doi-asserted-by":"crossref","DOI":"10.1007\/s40263-025-01223-2","article-title":"Sigma-1 Receptor Ligands for CNS Cancer Treatment","author":"Prasansuklab","year":"2025","journal-title":"CNS Drugs"},{"issue":"4","key":"10.1016\/j.biopha.2026.119618_bib34","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1021\/acsptsci.4c00711","article-title":"Recent advances in the development of sigma receptor (radio) ligands and their application in tumors","volume":"8","author":"Wang","year":"2025","journal-title":"ACS Pharmacol. & Transl. Sci."},{"issue":"21","key":"10.1016\/j.biopha.2026.119618_bib35","doi-asserted-by":"crossref","DOI":"10.1002\/cam4.71376","article-title":"The Sigma-1 Gene as a Prognostic Marker in Chemotherapy-Treated Breast Cancer-Antagonists' Synergism With Paclitaxel In Vitro","volume":"14","author":"Borde","year":"2025","journal-title":"Cancer Med."},{"issue":"sup1","key":"10.1016\/j.biopha.2026.119618_bib36","doi-asserted-by":"crossref","DOI":"10.1080\/2994399X.2024.2454759","article-title":"Sigma-1 Receptors & Disease (S1RaD) 2025","volume":"1","author":"Brimson","year":"2025","journal-title":"Geriatr. Pharmacol."},{"issue":"1","key":"10.1016\/j.biopha.2026.119618_bib37","doi-asserted-by":"crossref","first-page":"9251","DOI":"10.1038\/s41598-020-65849-6","article-title":"Simple ammonium salts acting on sigma-1 receptors yield potential treatments for cancer and depression","volume":"10","author":"Brimson","year":"2020","journal-title":"Sci. Rep."},{"issue":"9","key":"10.1016\/j.biopha.2026.119618_bib38","doi-asserted-by":"crossref","DOI":"10.3390\/molecules22091408","article-title":"Sigma Receptor (\u03c3R) Ligands with Antiproliferative and Anticancer Activity","volume":"22","author":"Georgiadis","year":"2017","journal-title":"Molecules"},{"issue":"7","key":"10.1016\/j.biopha.2026.119618_bib39","doi-asserted-by":"crossref","DOI":"10.3390\/cancers12071877","article-title":"The Biological Function of Sigma-2 Receptor\/TMEM97 and Its Utility in PET Imaging Studies in Cancer","volume":"12","author":"Zeng","year":"2020","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.biopha.2026.119618_bib40","doi-asserted-by":"crossref","first-page":"309","DOI":"10.3389\/fphar.2020.00309","article-title":"Hazards of Using Masking Protocols When Performing Ligand Binding Assays: Lessons From the Sigma-1 and Sigma-2 Receptors","volume":"11","author":"Abbas","year":"2020","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.biopha.2026.119618_bib41","doi-asserted-by":"crossref","first-page":"23","DOI":"10.3389\/fphar.2013.00023","article-title":"Inhibitory effects of sigma-2 receptor agonists on T lymphocyte activation","volume":"4","author":"Iniguez","year":"2013","journal-title":"Front. Pharmacol."},{"issue":"4","key":"10.1016\/j.biopha.2026.119618_bib42","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/j.ijsu.2005.05.002","article-title":"An introduction to death receptors in apoptosis","volume":"3","author":"Kumar","year":"2005","journal-title":"Int. J. Surg."},{"issue":"2","key":"10.1016\/j.biopha.2026.119618_bib43","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a041053","article-title":"The Death Receptor Pathway of Apoptosis","volume":"14","author":"Green","year":"2022","journal-title":"Cold Spring Harb. Perspect. Biol."},{"key":"10.1016\/j.biopha.2026.119618_bib44","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/B978-0-12-417158-9.00005-4","article-title":"A, Apoptosis initiation through the cell-extrinsic pathway","volume":"544","author":"Nair","year":"2014","journal-title":"Methods Enzymol."},{"issue":"1","key":"10.1016\/j.biopha.2026.119618_bib45","doi-asserted-by":"crossref","DOI":"10.1042\/BSR20180992","article-title":"Apoptosis and apoptotic body: disease message and therapeutic target potentials","volume":"39","author":"Xu","year":"2019","journal-title":"Biosci. Rep."},{"key":"10.1016\/j.biopha.2026.119618_bib46","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1039\/C5MD00079C","article-title":"Novel indole-based sigma-2 receptor ligands: synthesis, structure\u2013affinity relationship and antiproliferative activity","volume":"6","author":"Xie","year":"2015","journal-title":"MedChemComm"},{"key":"10.1016\/j.biopha.2026.119618_bib47","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1007\/978-1-62703-236-0_9","article-title":"Determine the effect of p53 on chemosensitivity","volume":"962","author":"Senturk","year":"2013","journal-title":"Methods Mol. Biol."},{"issue":"1","key":"10.1016\/j.biopha.2026.119618_bib48","doi-asserted-by":"crossref","first-page":"994","DOI":"10.3390\/cancers3010994","article-title":"Role of p53 in Cell Death and Human Cancers","volume":"3","author":"Ozaki","year":"2011","journal-title":"Cancers (Basel)"},{"issue":"28","key":"10.1016\/j.biopha.2026.119618_bib49","doi-asserted-by":"crossref","first-page":"3943","DOI":"10.1038\/onc.2016.502","article-title":"Census and evaluation of p53 target genes","volume":"36","author":"Fischer","year":"2017","journal-title":"Oncogene"},{"issue":"5","key":"10.1016\/j.biopha.2026.119618_bib50","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1038\/s41418-022-00988-z","article-title":"Cell cycle regulation: p53-p21-RB signaling","volume":"29","author":"Engeland","year":"2022","journal-title":"Cell. Death Differ."},{"key":"10.1016\/j.biopha.2026.119618_bib51","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1100\/tsw.2001.297","article-title":"Ensuring the stability of the genome: DNA damage checkpoints","volume":"1","author":"Latif","year":"2001","journal-title":"ScientificWorldJournal"},{"key":"10.1016\/j.biopha.2026.119618_bib52","series-title":"Kidney Development Disease Repair and Regeneration","first-page":"367","article-title":"Chapter 27 - The Molecular Response to Renal Injury: How Does Chronic Renal Damage Suppress Normal Repair Processes?","author":"Ferenbach DA","year":"2016"},{"issue":"3","key":"10.1016\/j.biopha.2026.119618_bib53","doi-asserted-by":"crossref","first-page":"a026104","DOI":"10.1101\/cshperspect.a026104","article-title":"The Cell-Cycle Arrest and Apoptotic Functions of p53 in Tumor Initiation and Progression","volume":"6","author":"Chen","year":"2016","journal-title":"Cold Spring Harb. Perspect. Med."},{"issue":"1","key":"10.1016\/j.biopha.2026.119618_bib54","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1002\/path.2697","article-title":"Autophagy: cellular and molecular mechanisms","volume":"221","author":"Glick","year":"2010","journal-title":"J. Pathol."},{"issue":"4","key":"10.1016\/j.biopha.2026.119618_bib55","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1038\/s41418-018-0252-y","article-title":"Autophagy-dependent cell death","volume":"26","author":"Denton","year":"2019","journal-title":"Cell. Death Differ."},{"key":"10.1016\/j.biopha.2026.119618_bib56","doi-asserted-by":"crossref","DOI":"10.1016\/j.brainres.2021.147747","article-title":"Dependence of glucose transport on autophagy and GAPDH activity","volume":"1776","author":"Craven","year":"2022","journal-title":"Brain Res."},{"issue":"24","key":"10.1016\/j.biopha.2026.119618_bib57","doi-asserted-by":"crossref","first-page":"4672","DOI":"10.1111\/febs.13540","article-title":"p62\/SQSTM1 functions as a signaling hub and an autophagy adaptor","volume":"282","author":"Katsuragi","year":"2015","journal-title":"FEBS J."},{"key":"10.1016\/j.biopha.2026.119618_bib58","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2022.793328","article-title":"Selective Autophagy Receptor p62\/SQSTM1, a Pivotal Player in Stress and Aging","volume":"10","author":"Kumar","year":"2022","journal-title":"Front. Cell. Dev. Biol."},{"issue":"3-4","key":"10.1016\/j.biopha.2026.119618_bib59","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1007\/s10495-018-1445-z","article-title":"Role of p62 in the regulation of cell death induction","volume":"23","author":"Fan","year":"2018","journal-title":"Apoptosis"},{"issue":"4","key":"10.1016\/j.biopha.2026.119618_bib60","doi-asserted-by":"crossref","DOI":"10.3892\/ijo.2021.5257","article-title":"Sequestosome 1\/p62: a multitasker in the regulation of malignant tumor aggression (Review)","volume":"59","author":"Tang","year":"2021","journal-title":"Int. J. Oncol."},{"issue":"13","key":"10.1016\/j.biopha.2026.119618_bib61","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.3390\/cells14131016","article-title":"Post-Translational Modification of p62: Roles and Regulations in Autophagy","volume":"14","author":"Xiao","year":"2025","journal-title":"Cells"},{"issue":"1","key":"10.1016\/j.biopha.2026.119618_bib62","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2013.520","article-title":"Modulation of apoptosis sensitivity through the interplay with autophagic and proteasomal degradation pathways","volume":"5","author":"Delgado","year":"2014","journal-title":"Cell. Death Dis."},{"issue":"15","key":"10.1016\/j.biopha.2026.119618_bib63","doi-asserted-by":"crossref","first-page":"12455","DOI":"10.1074\/jbc.M111.309104","article-title":"Autophagosomal membrane serves as platform for intracellular death-inducing signaling complex (iDISC)-mediated caspase-8 activation and apoptosis","volume":"287","author":"Young","year":"2012","journal-title":"J. Biol. Chem."},{"issue":"6","key":"10.1016\/j.biopha.2026.119618_bib64","doi-asserted-by":"crossref","first-page":"4030","DOI":"10.1111\/jcmm.14288","article-title":"p62 aggregates mediated Caspase 8 activation is responsible for progression of ovarian cancer","volume":"23","author":"Yan","year":"2019","journal-title":"J. Cell. Mol. Med."},{"key":"10.1016\/j.biopha.2026.119618_bib65","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2019.101392","article-title":"Triggering apoptosis by oroxylin A through caspase-8 activation and p62\/SQSTM1 proteolysis","volume":"29","author":"Zhao","year":"2020","journal-title":"Redox Biol."},{"issue":"3","key":"10.1016\/j.biopha.2026.119618_bib66","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20030473","article-title":"Thioridazine Enhances P62-Mediated Autophagy and Apoptosis Through Wnt\/beta-Catenin Signaling Pathway in Glioma Cells","volume":"20","author":"Chu","year":"2019","journal-title":"Int. J. Mol. Sci."},{"issue":"8","key":"10.1016\/j.biopha.2026.119618_bib67","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1038\/cdd.2017.43","article-title":"Caspase involvement in autophagy","volume":"24","author":"Tsapras","year":"2017","journal-title":"Cell. Death Differ."},{"issue":"3","key":"10.1016\/j.biopha.2026.119618_bib68","doi-asserted-by":"crossref","first-page":"284","DOI":"10.3390\/cells1030284","article-title":"Regulation of the autophagic bcl-2\/beclin 1 interaction","volume":"1","author":"Decuypere","year":"2012","journal-title":"Cells"},{"issue":"1","key":"10.1016\/j.biopha.2026.119618_bib69","doi-asserted-by":"crossref","DOI":"10.3892\/ijmm.2021.4957","article-title":"Neferine promotes the apoptosis of HNSCC through the accumulation of p62\/SQSTM1 caused by autophagic flux inhibition","volume":"48","author":"Zhu","year":"2021","journal-title":"Int. J. Mol. Med."},{"key":"10.1016\/j.biopha.2026.119618_bib70","doi-asserted-by":"crossref","first-page":"310","DOI":"10.3389\/fnmol.2018.00310","article-title":"p62-Keap1-NRF2-ARE pathway: a contentious player for selective targeting of autophagy, oxidative stress and mitochondrial dysfunction in prion diseases","volume":"11","author":"Shah","year":"2018","journal-title":"Front. Mol. Neurosci."},{"issue":"5","key":"10.1016\/j.biopha.2026.119618_bib71","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1038\/s41419-024-06693-8","article-title":"Cytotoxic sigma-2 ligands trigger cancer cell death via cholesterol-induced-ER-stress","volume":"15","author":"Takchi","year":"2024","journal-title":"Cell. Death & Dis."},{"key":"10.1016\/j.biopha.2026.119618_bib72","doi-asserted-by":"crossref","first-page":"862","DOI":"10.3389\/fnins.2019.00862","article-title":"Neuronal sigma-1 receptors: signaling functions and protective roles in neurodegenerative diseases","volume":"13","author":"Ryskamp","year":"2019","journal-title":"Front. Neurosci."},{"issue":"1","key":"10.1016\/j.biopha.2026.119618_bib73","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12929-017-0380-6","article-title":"Roles of sigma-1 receptors on mitochondrial functions relevant to neurodegenerative diseases","volume":"24","author":"Weng","year":"2017","journal-title":"J. Biomed. Sci."}],"container-title":["Biomedicine &amp; Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332226006542?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332226006542?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,22]],"date-time":"2026-08-22T22:52:16Z","timestamp":1787439136000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332226006542"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":73,"alternative-id":["S0753332226006542"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2026.119618","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Sigma-1 Receptor antagonism potentiates siramesine-induced apoptosis and altered autophagic signaling in human leukemia cells","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2026.119618","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"119618"}}